|
|
How is rheumatoid
arthritis diagnosed?
The first step in the diagnosis of rheumatoid arthritis
is a meeting between the doctor and the patient. The doctor
reviews the history of symptoms, examines the joints for
inflammation and deformity, the skin for rheumatoid nodules,
and other parts of the body for inflammation. Certain blood
and x-ray tests are often obtained. The diagnosis will be
based on the pattern of symptoms, the distribution of the
inflamed joints, and the blood and x-ray findings. Several
visits may be necessary before the doctor can be certain of
the diagnosis. A doctor with special training in arthritis and
related diseases is called a
rheumatologist.
The distribution of
joint inflammation is important to the doctor in making a
diagnosis. In rheumatoid arthritis, the small joints of the
hands, wrists, feet, and knees are typically inflamed in a
symmetrical distribution (affecting both sides of the body).
When only one or two joints are inflamed, the diagnosis of
rheumatoid arthritis becomes more difficult. The doctor may
then perform other tests to exclude arthritis due to infection
or gout. The detection of rheumatoid nodules (described
above), most often around the elbows and fingers, can suggest
the diagnosis.
Abnormal blood
antibodies can be found in patients with rheumatoid arthritis.
A blood antibody called "rheumatoid factor" can be found in
80% of patients. Citrulline antibody (also referred to as
anti-citrulline antibody, anti-cyclic citrullinated peptide
antibody, and anti-CCP) is present in most patients with
rheumatoid arthritis. It is useful in the diagnosis of
rheumatoid arthritis when evaluating patients with unexplained
joint inflammation. A test for citrulline antibodies is most
helpful in looking for the cause of previously undiagnosed
inflammatory arthritis when the traditional blood test for
rheumatoid arthritis, rheumatoid factor, is not present.
Citrulline antibodies have been felt to represent the earlier
stages of rheumatoid arthritis in this setting. Another
antibody called "the antinuclear antibody" (ANA) is also
frequently found in patients with rheumatoid
arthritis.
A blood test called
the sedimentation rate (sed rate) is a measure of how fast red
blood cells fall to the bottom of a test tube. The sed rate is
used as a crude measure of the inflammation of the joints. The
sed rate is usually faster during disease flares, and slower
during remissions. Another blood test that is used to measure
the degree of inflammation present in the body is the
C-reactive protein. The rheumatoid factor, ANA, sed rate, and
C-reactive protein tests can also be abnormal in other
systemic autoimmune and inflammatory conditions. Therefore,
abnormalities in these blood tests alone are not sufficient
for a firm diagnosis of rheumatoid arthritis.
Joint x-rays may be
normal or only show swelling of soft tissues early in the
disease. As the disease progresses x-rays can show bony
erosions typical of rheumatoid arthritis in the joints. Joint
x-rays can also be helpful in monitoring the progression of
disease and joint damage over time. Bone scanning, a
radioactive test procedure, can demonstrate the inflamed
joints.
The doctor may
elect to perform an office procedure called arthrocentesis. In
this procedure, a sterile needle and syringe are used to drain
joint fluid out of the joint for study in the laboratory.
Analysis of the joint fluid, in the laboratory, can help to
exclude other causes of arthritis, such as infection and gout.
Arthrocentesis can also be helpful in relieving joint swelling
and pain. Occasionally, cortisone medications are injected
into the joint during the arthrocentesis in order to rapidly
relieve joint inflammation and further reduce
symptoms.
There is no single
test that can confirm the diagnosis of rheumatoid arthritis.
Your health care provider will use the results of your
interview and physical examination, lab tests, and imaging
studies such as x-rays to determine whether you have
rheumatoid arthritis. At any time in the process of making the
diagnosis or treating the condition, your primary care
provider may refer you to a rheumatologist (a specialist in
diagnosing and treating rheumatic diseases such as rheumatoid
arthritis).
Lab tests: Your health care
provider may run any of the following tests:
- Complete blood count: This
test measures how many of each type of blood cell are in
your blood. This will show anemia as well as other
irregularities that could indicate rheumatoid arthritis.
- Markers of inflammation: These
include measures such as erythrocyte sedimentation rate
(ESR) and C-reactive protein (CRP). Levels of both of these
are usually high in rheumatoid arthritis and may be good
indicators of the extent of disease activity at any given
time.
- Other blood tests: Levels of
electrolytes
(such as calcium, magnesium, and potassium) and proteins may
be tested. Kidney and liver functions also may be checked.
- Immunologic tests: Levels of
rheumatoid factor (RF), antinuclear antibodies (ANA), and possibly
other antibodies (anti-RA33, anti-CCP) may be checked. The
majority of people have a positive RF result during the
disease’s active periods. A positive ANA result indicates
an unusually active immune system. About 40% of people with
rheumatoid arthritis have a positive ANA result. In the
first few months of onset of rheumatoid arthritis, these
immunologic tests may be negative, and, in some patients,
they are always negative.
Synovial fluid analysis: The
synovium produces fluid that helps lubricate and protect
joints. Like blood, this fluid may be abnormal in rheumatoid
arthritis. It may reveal characteristic signs of
inflammation that point to rheumatoid arthritis, such as
white blood cells. A sample of this fluid is withdrawn from a
joint (usually the knee) through a needle in a procedure
called arthrocentesis, or joint aspiration. The fluid is
examined and analyzed for signs of inflammation.
Imaging studies: X-rays and
sometimes other imaging studies often are used to detect
damage to the joints.
- X-rays: X-rays may be taken of
sites where symptoms or signs occur. Early in rheumatoid
arthritis, the x-ray may be normal or show only soft tissue
swelling, but damage can still be occurring. Over time, the
usual finding is erosion of the bony part of the joint.
These changes are distinguishable from changes seen with
other types of arthritis such as osteoarthritis.
- MRI: MRI may allow earlier
detection of bone erosion than x-rays.
- Ultrasound: Ultrasound uses
high-frequency sound waves to take pictures of structures
inside the body. It can be used to examine and to detect
abnormal collections of fluid (effusions, which cause
swelling) in the soft tissues around joints that are not
easily accessible (such as hip joints or shoulder joints in
obese patients).
- Bone scanning: In this test, a
special picture of the entire skeleton is taken after a
harmless radioactive isotope is injected into a vein.
Diseased or damaged bone takes up the radioisotope in a
different way than healthy bone and gives a characteristic
picture. This technique may be used to detect inflammatory
changes in bone.
- Densitometry: This scan
detects changes in the thickness of bone that may indicate
osteoporosis.
- Arthroscopy: A small scope, a
long narrow tube with a light and a camera on the end, is
used to examine the inside of the joint. The scope is
inserted through a small incision in the skin. The camera
transmits pictures to a video monitor, allowing the doctor
to detect signs of rheumatoid arthritis or other joint
disease. This test is not always necessary.
Classification
The American College of
Rheumatology has developed a system for classifying rheumatoid
arthritis. This system helps medical professionals determine
the severity of your rheumatoid arthritis.
Stage I
- No damage seen on x-rays,
although there may be signs of bone thinning
Stage II
- On x-ray, evidence of bone
thinning around a joint with or without slight
bone damage
- Slight cartilage damage
possible
- Joint mobility may be limited;
no joint deformities observed
- Atrophy of adjacent muscle
- Abnormalities of soft tissue
around joint possible
Stage III
- On x-ray, evidence of
cartilage and bone damage and bone thinning around the
joint
- Joint deformity without
permanent stiffening or fixation of the joint
- Extensive muscle atrophy
- Abnormalities of soft tissue
around joint possible
Stage IV
- On x-ray, evidence of
cartilage and bone damage and osteoporosis around joint
- Joint deformity with permanent
stiffening or fixation of the joint (ankylosis)
- Extensive muscle atrophy
- Abnormalities of soft tissue
around joint possible
Rheumatologists also classify
the functional status of persons with rheumatoid arthritis, as
follows:
- Class I - Completely able to
perform usual activities of daily living
- Class II - Able to perform
usual self-care and work activities but limited in
activities outside of work (such as playing sports,
household chores)
- Class III - Able to perform
usual self-care activities but limited in work and other
activities
- Class IV - Limited in ability
to perform usual self-care, work, and other
activities
|
Note: Click for more
|
|
|
Free Health
Facts |
|
We have the largest selection of
Health Information 100% FREE for those who want to
learn about
Health. | Featured
Sites |
|
 |
|
|
| |